ロード中...
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 mainly causes damage to the lung, as well as other organs and systems such as the hearts, the immune system and so on. Although the pathogen...
保存先:
| 出版年: | Cell Prolif |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7645923/ https://ncbi.nlm.nih.gov/pubmed/33098357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12939 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|